Malignant Neoplasm

Oncology·MeSH: Neoplasms

Prevalence

26.2 / 100K

Incidence

6.0 / 100K/yr

7 drugs in development·2 companies·11 clinical trials

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Malignant Neoplasm?

BioSniper tracks 7 drugs in development for Malignant Neoplasm across 2 companies.

How many clinical trials target Malignant Neoplasm?

There are 11 clinical trials targeting Malignant Neoplasm tracked by BioSniper.

What is the prevalence of Malignant Neoplasm?

The estimated prevalence of Malignant Neoplasm is approximately 26.2 per 100,000 population.

Deep-dive into Malignant Neoplasm

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Malignant Neoplasm — Drugs in Development & Clinical Trials | BioSniper